2012 ACR/ARHP Annual Meeting

November 9-14, 2012. Washington, DC.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1181

The Role of á-Defensin-1 and Its Signal Transduction Mechanisms in the Production of IL-6, IL-8 and MMPs in Rheumatoid Fibroblast-Like Synoviocytes
Abstract Number: 890

The Role of Adipocytokines in Osteophyte Formation in Osteoarthritis
Abstract Number: 2453

The Role of Bob1 in Rheumatoid Arthritis: Potential Implications for Autoimmunity
Abstract Number: 725

The Role of Interleukin-23 in Spondyloarthropathy
Abstract Number: 1817

The Role of Repeating Tuberculin Skin Tests During Biologic Therapy
Abstract Number: 1230

The Role of Sleep Problems in Conditioned Pain Modulation in Rheumatoid Arthritis
Abstract Number: 1763

The Role of SYK in Human B CELL Activation and Its Relevance to Autoimmune Diseases
Abstract Number: 2288

The Role of TCR Vä1⁺ NKT Cells in Systemic Sclerosis Patients with Interstitial Pneumonitis
Abstract Number: 1854

The Safety of Anti-TNF Biologic Agents in Rheumatoid Arthritis – A Meta-Analysis of 35 RCTs
Abstract Number: 2021

The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven by the Phenotype Severity Rather Than the Age
Abstract Number: 739

The Serine Arginine Protein SF2/ASF Is a Novel Regulator of IL-2 Transcription and Restores IL-2 Production in T Lymphocytes From SLE Patients
Abstract Number: 1213

The Serum Cytokine Profile of Interstitial Lung Disease in Rheumatoid Arthritis
Abstract Number: 1180

The Sex-Determining Region Y Box 6 Locus: Shared Genetic Susceptibility Between Rheumatoid Arthritis and Psychotic Disorder
Abstract Number: 2697

The Short Term Effect of Individualized Nutrition Counseling On Nutrients and Select Cardiovascular Risk Factors in Patients with Systemic Lupus Erythematosus
Abstract Number: 429

The Significance of the Apoptosis Level and the Apoptosis Related Signal Proteins of CD4⁺t�ACD4⁺Foxp3⁺t Cell in Patients with Rheumatoid Arthritis

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].